Literature DB >> 8857934

Erythropoietin production by interstitial cells of hypoxic monkey kidneys.

J W Fisher1, S Koury, T Ducey, S Mendel.   

Abstract

Previous studies which demonstrated that interstitial cells of the peritubular capillary bed of the kidneys are the site of erythropoietin (Epo) production have been performed in non-primate species. In this study, kidneys from adult rhesus monkeys exposed to 18 h hypoxia (0.42 atm) with high serum (5685 mU/ml) and kidney (814 mU/g. includes serum EPO in the kidney) levels of Epo were compared with a kidney from a nonhypoxic normal rhesus monkey. Localization of Epo mRNA by in situ hybridization was carried out with either anti-sense or sense RNA probes generated from a 645 base pair KpnI-BgIII fragment of a monkey Epo cDNA. Epo mRNA was demonstrated only in interstitial cells in the peritubular capillary bed of the hypoxic and normal monkey kidneys utilizing the antisense probe. The finding that the same type of cell that produces EPO in mice, rats and sheep also produces EPO in a higher primate species strongly supports the contention that renal interstitial cells also produce EPO in the human.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8857934     DOI: 10.1046/j.1365-2141.1996.d01-1864.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  17 in total

Review 1.  Erythropoietin produced by the retina: its role in physiology and diabetic retinopathy.

Authors:  Cristina Hernández; Rafael Simó
Journal:  Endocrine       Date:  2011-12-14       Impact factor: 3.633

Review 2.  Clinical pharmacokinetics and pharmacodynamics of erythropoiesis-stimulating agents.

Authors:  Sameer Doshi; Wojciech Krzyzanski; Susan Yue; Steven Elliott; Andrew Chow; Juan José Pérez-Ruixo
Journal:  Clin Pharmacokinet       Date:  2013-12       Impact factor: 6.447

3.  Progress toward a nonviral gene therapy protocol for the treatment of anemia.

Authors:  Magdolna G Sebestyén; Julia O Hegge; Mark A Noble; David L Lewis; Hans Herweijer; Jon A Wolff
Journal:  Hum Gene Ther       Date:  2007-03       Impact factor: 5.695

Review 4.  Systematic Review of Erythropoietin (EPO) for Neuroprotection in Human Studies.

Authors:  Salman Hemani; Olabisi Lane; Sunil Agarwal; Shan Ping Yu; Anna Woodbury
Journal:  Neurochem Res       Date:  2021-02-01       Impact factor: 3.996

Review 5.  Anemia of thermal injury: combined acute blood loss anemia and anemia of critical illness.

Authors:  Joseph A Posluszny; Richard L Gamelli
Journal:  J Burn Care Res       Date:  2010 Mar-Apr       Impact factor: 1.845

6.  Erythropoietin ameliorates the reduced migration of human fibroblasts during in vitro hypoxia.

Authors:  Stephanie Breit; Monika Bubel; Tim Pohlemann; Martin Oberringer
Journal:  J Physiol Biochem       Date:  2010-09-04       Impact factor: 4.158

7.  EPO receptor circuits for primary erythroblast survival.

Authors:  Pradeep Sathyanarayana; Arvind Dev; Jing Fang; Estelle Houde; Olga Bogacheva; Oleg Bogachev; Madhu Menon; Sarah Browne; Anamika Pradeep; Christine Emerson; Don M Wojchowski
Journal:  Blood       Date:  2008-03-18       Impact factor: 22.113

Review 8.  Erythropoietin doping in cycling: lack of evidence for efficacy and a negative risk-benefit.

Authors:  Jules A A C Heuberger; Joost M Cohen Tervaert; Femke M L Schepers; Adriaan D B Vliegenthart; Joris I Rotmans; Johannes M A Daniels; Jacobus Burggraaf; Adam F Cohen
Journal:  Br J Clin Pharmacol       Date:  2013-06       Impact factor: 4.335

9.  A lentiviral gene therapy strategy for the in vitro production of feline erythropoietin.

Authors:  Natalia Vapniarsky; Michael Lame; Samantha McDonnel; Brian Murphy
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240

Review 10.  Functional significance of erythropoietin in renal cell carcinoma.

Authors:  Christudas Morais; David W Johnson; David A Vesey; Glenda C Gobe
Journal:  BMC Cancer       Date:  2013-01-10       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.